S.F. Holding (06936) wholly-owned subsidiary intends to contribute RMB 100 million to participate in investing in an equity investment fund.
S.F. Holding (06936) announced that, in order to promote the company's long-term development and achieve positive interaction between industrial operations and capital operations, on September 21, 2026, the company's wholly-owned subsidiary Shenzhen S.F. Investment Co., Ltd. signed the "Hangzhou Chuangyi Future Equity Investment Partnership (Limited Partnership) Partnership Agreement". Hangzhou Chuangyi Future Equity Investment Partnership (Limited Partnership) is a comprehensive industry strategy fund focused on pan-hard technology, mainly investing in growth-stage enterprises while also covering investments in some early-stage, high-growth enterprises.
S.F. Holding (06936) announced that, in order to promote the company's long-term development and achieve a virtuous interaction between industrial operations and capital operations, on September 21, 2026, the company's wholly-owned subsidiary Shenzhen SF Investment Co., Ltd. signed the "Hangzhou Chuangyi Future Equity Investment Partnership (Limited Partnership) Partnership Agreement." Hangzhou Chuangyi Future Equity Investment Partnership (Limited Partnership) is a comprehensive industry strategy fund focused on pan-hard technology, mainly investing in growth-stage enterprises while also making investments in some early-stage, high-growth enterprises. The target total size of the fund and parallel investment vehicles is RMB 7 billion. As of now, the fund's total subscribed capital contributions amount to RMB 3.72123 billion, of which SF Investment, as a limited partner, has subscribed RMB 100 million.
Related Articles

US Stock Market Move | Capital Markets Day $23 Billion Target Falls Short of Expectations, Novo Nordisk A/S Sponsored ADR Class B (NVO.US) Drops Over 8%

CF PHARMTECH (02652): ICF004 Completes Dosing of First Healthy Volunteer in Phase I Clinical Trial

US Stock Market Move | Paramount Skydance may clear acquisition hurdles; Warner Bros. Discovery (WBD.US) rises over 10%.
US Stock Market Move | Capital Markets Day $23 Billion Target Falls Short of Expectations, Novo Nordisk A/S Sponsored ADR Class B (NVO.US) Drops Over 8%

CF PHARMTECH (02652): ICF004 Completes Dosing of First Healthy Volunteer in Phase I Clinical Trial

US Stock Market Move | Paramount Skydance may clear acquisition hurdles; Warner Bros. Discovery (WBD.US) rises over 10%.

RECOMMEND





